Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
1.935
-0.385 (-16.59%)
Mar 18, 2026, 1:35 PM EDT - Market open
RVPH Market Cap
RVPH has a market cap or net worth of $226.1 million as of March 18, 2026. Its market cap has increased by 279.23% in one year.
Market Cap
226.10M
Enterprise Value
231.03M
1-Year Change
279.23%
Ranking
Category
Stock Price
$1.94
Market Cap Chart
Since October 18, 2018, RVPH's market cap has increased from $25.21M to $226.10M, an increase of 796.89%. That is a compound annual growth rate of 34.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 13.55M | -58.42% |
| Dec 31, 2025 | 32.60M | -61.33% |
| Dec 31, 2024 | 84.31M | -41.36% |
| Dec 29, 2023 | 143.78M | 65.49% |
| Dec 30, 2022 | 86.88M | 115.01% |
| Dec 31, 2021 | 40.41M | -49.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crescent Biopharma | 308.08M |
| AC Immune | 306.85M |
| Polaryx Therapeutics | 301.10M |
| Puma Biotechnology | 300.17M |
| Cabaletta Bio | 294.57M |
| Nautilus Biotechnology | 294.29M |
| Palisade Bio | 289.07M |
| Foghorn Therapeutics | 287.63M |